ES2109954T3 - Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento. - Google Patents

Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento.

Info

Publication number
ES2109954T3
ES2109954T3 ES92103334T ES92103334T ES2109954T3 ES 2109954 T3 ES2109954 T3 ES 2109954T3 ES 92103334 T ES92103334 T ES 92103334T ES 92103334 T ES92103334 T ES 92103334T ES 2109954 T3 ES2109954 T3 ES 2109954T3
Authority
ES
Spain
Prior art keywords
growth
antibody
antiidiotipic
stimulation
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92103334T
Other languages
English (en)
Inventor
Bosco S Wang
Araceli L Lumanglas
Eugene Szewcyzk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2109954T3 publication Critical patent/ES2109954T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION ACTUAL ESTA DIRIGIDA A LA GENERACION DE ANTICUERPOS ANTI-IDIOTIPICOS ADMINISTRANDO A LOS VERTEBRADOS EL ANTICUERPO DE UN POLIPEPTIDO DE POTENCIACION DEL CRECIMIENTO. LOS ANTICUERPOS ANTI-IDIOTIPICOS IMITAN LA ACTIVIDAD DEL POLIPEPTIDO ESTIMULANDO EL CRECIMIENTO DE LOS VERTEBRADOS. LA INVENCION ESTA DIRIGIDO TAMBIEN A LOS ANTICUERPOS ANTI-IDIOTIPICOS PARA FRAGMENTAR LOS ANTICUERPOS DE UN POLIPEPTIDO DE POTENCIACION DEL CRECIMIENTO.
ES92103334T 1991-04-03 1992-02-27 Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento. Expired - Lifetime ES2109954T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68018291A 1991-04-03 1991-04-03

Publications (1)

Publication Number Publication Date
ES2109954T3 true ES2109954T3 (es) 1998-02-01

Family

ID=24730050

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92103334T Expired - Lifetime ES2109954T3 (es) 1991-04-03 1992-02-27 Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento.

Country Status (14)

Country Link
EP (1) EP0502416B1 (es)
JP (1) JPH05252985A (es)
KR (1) KR920019374A (es)
AT (1) ATE160786T1 (es)
AU (1) AU659830B2 (es)
CA (1) CA2064635A1 (es)
DE (1) DE69223337T2 (es)
DK (1) DK0502416T3 (es)
ES (1) ES2109954T3 (es)
GR (1) GR3026132T3 (es)
IE (1) IE921042A1 (es)
IL (1) IL101450A0 (es)
NZ (1) NZ242168A (es)
ZA (1) ZA922421B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742662B1 (fr) * 1995-12-21 1998-01-23 Centre Nat Rech Scient Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments
JP5985481B2 (ja) * 2010-09-01 2016-09-06 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 抗イディオタイプ抗体の迅速な産生

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210180A (en) * 1989-10-27 1993-05-11 American Cyanamid Company Enhancement of porcine somatotropin activity
US5439795A (en) * 1990-01-31 1995-08-08 American Cyanamid Company Monoclonal antibodies that specifically bind somatotropin binding proteins but not to corresponding somatotropin receptors and methods of use in immunoassays

Also Published As

Publication number Publication date
IE921042A1 (en) 1992-10-07
EP0502416B1 (en) 1997-12-03
DE69223337D1 (de) 1998-01-15
EP0502416A1 (en) 1992-09-09
AU659830B2 (en) 1995-06-01
ATE160786T1 (de) 1997-12-15
ZA922421B (en) 1992-12-30
KR920019374A (ko) 1992-11-19
JPH05252985A (ja) 1993-10-05
DE69223337T2 (de) 1998-03-26
AU1400692A (en) 1992-10-08
NZ242168A (en) 1993-11-25
IL101450A0 (en) 1992-12-30
CA2064635A1 (en) 1992-10-04
GR3026132T3 (en) 1998-05-29
DK0502416T3 (da) 1998-01-12

Similar Documents

Publication Publication Date Title
DK0481058T3 (da) Humant, lymfatisk væv i en immunokompromitteret vært
ATE156698T1 (de) Inhibitierung des haarwuchses
ES2059413T3 (es) Anticuerpos monoclonales contra antigenos asociados a melanoma, progenies celulares hibridas que producen estos anticuerpos, y su empleo correspondiente.
ES2112860T3 (es) Inmunoterapia adoptiva con interleukina-7.
DE69329503D1 (de) Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
DE3875700D1 (de) Wirkstoff - monoklonale antikoerper - konjugate.
DE3884739D1 (de) Nichtinvasiver Herzschrittmacher mit rampenförmiger Welle.
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
ATE55256T1 (de) Verwendung des diterpen-derivates forskolin zur immunstimulation.
SE8008415L (sv) Cyklisk analog for fagocytosstimulerande naturpeptid, dvs treonyl-cyklo-(-n-lysyl-prolyl-arginyl-)
DE69213943D1 (de) Kurzzeitige stimulierung von lymphozyten mit anti-cd3 antikörpern um ihre in vivo aktivität zu steigern
ES2055686T3 (es) Procedimiento para preparar proteinas con factor de granulocitos-macrofagos "estimulador de colonias".
ES2109954T3 (es) Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento.
DE69230224D1 (de) Potenzierung von nmda-antagonisten
FI881420A (fi) Voimalaitos, jossa palaminen tapahtuu leijukerroksessa
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
DK0546036T3 (da) Vacciner
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
ATE141102T1 (de) Regulierung der genexpression
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
UA13003A (uk) Засіб для стимулюваhhя hавчаhhя та пам'яті
DE3876788D1 (de) Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.
SU1565021A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus - продуцент моноклональных антител к вирусу ящура 0-01618
ES2076399T3 (es) Estimulacion inmunologica del efecto somatogenico de la somatotropina con un anticuerpo.
SU1459236A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к listeria monocytogenes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 502416

Country of ref document: ES